Literature DB >> 28808947

The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease.

W Linke1, C G Dos Remedios2, S P Lal3, A Li3,4, J McNamara3, A Keogh5, P S Macdonald5, R Cooke6, E Ehler7, R Knöll8, S B Marston9, J Stelzer10, H Granzier11, C Bezzina12, S van Dijk13, F De Man13, G J M Stienen13, J Odeberg14, F Pontén15, J van der Velden13.   

Abstract

The Sydney Heart Bank (SHB) is one of the largest human heart tissue banks in existence. Its mission is to provide high-quality human heart tissue for research into the molecular basis of human heart failure by working collaboratively with experts in this field. We argue that, by comparing tissues from failing human hearts with age-matched non-failing healthy donor hearts, the results will be more relevant than research using animal models, particularly if their physiology is very different from humans. Tissue from heart surgery must generally be used soon after collection or it significantly deteriorates. Freezing is an option but it raises concerns that freezing causes substantial damage at the cellular and molecular level. The SHB contains failing samples from heart transplant patients and others who provided informed consent for the use of their tissue for research. All samples are cryopreserved in liquid nitrogen within 40 min of their removal from the patient, and in less than 5-10 min in the case of coronary arteries and left ventricle samples. To date, the SHB has collected tissue from about 450 failing hearts (>15,000 samples) from patients with a wide range of etiologies as well as increasing numbers of cardiomyectomy samples from patients with hypertrophic cardiomyopathy. The Bank also has hearts from over 120 healthy organ donors whose hearts, for a variety of reasons (mainly tissue-type incompatibility with waiting heart transplant recipients), could not be used for transplantation. Donor hearts were collected by the St Vincent's Hospital Heart and Lung transplantation team from local hospitals or within a 4-h jet flight from Sydney. They were flushed with chilled cardioplegic solution and transported to Sydney where they were quickly cryopreserved in small samples. Failing and/or donor samples have been used by more than 60 research teams around the world, and have resulted in more than 100 research papers. The tissues most commonly requested are from donor left ventricles, but right ventricles, atria, interventricular system, and coronary arteries vessels have also been reported. All tissues are stored for long-term use in liquid N or vapor (170-180 °C), and are shipped under nitrogen vapor to avoid degradation of sensitive molecules such as RNAs and giant proteins. We present evidence that the availability of these human heart samples has contributed to a reduction in the use of animal models of human heart failure.

Entities:  

Keywords:  Healthy donor human hearts; Human heart failure; Human heart tissue bank; Reducing the use of animals in research

Year:  2017        PMID: 28808947      PMCID: PMC5578936          DOI: 10.1007/s12551-017-0305-3

Source DB:  PubMed          Journal:  Biophys Rev        ISSN: 1867-2450


  48 in total

Review 1.  Top-down mass spectrometry of cardiac myofilament proteins in health and disease.

Authors:  Ying Peng; Serife Ayaz-Guner; Deyang Yu; Ying Ge
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

2.  Elevated DNase I levels in human idiopathic dilated cardiomyopathy: an indicator of apoptosis?

Authors:  M Yao; A Keogh; P Spratt; C G dos Remedios; P C Kiessling
Journal:  J Mol Cell Cardiol       Date:  1996-01       Impact factor: 5.000

3.  Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series.

Authors:  Kumud K Dhital; Arjun Iyer; Mark Connellan; Hong C Chew; Ling Gao; Aoife Doyle; Mark Hicks; Gayathri Kumarasinghe; Claude Soto; Andrew Dinale; Bruce Cartwright; Priya Nair; Emily Granger; Paul Jansz; Andrew Jabbour; Eugene Kotlyar; Anne Keogh; Christopher Hayward; Robert Graham; Phillip Spratt; Peter Macdonald
Journal:  Lancet       Date:  2015-04-14       Impact factor: 79.321

4.  Protective effect of phosphorylated Hsp27 in coronary arteries through actin stabilization.

Authors:  Aisling A Robinson; Michael J Dunn; Ann McCormack; Cris dos Remedios; Marlene L Rose
Journal:  J Mol Cell Cardiol       Date:  2010-06-20       Impact factor: 5.000

5.  Coxsackie and adenovirus receptor is a modifier of cardiac conduction and arrhythmia vulnerability in the setting of myocardial ischemia.

Authors:  Roos F J Marsman; Connie R Bezzina; Fabian Freiberg; Arie O Verkerk; Michiel E Adriaens; Svitlana Podliesna; Chen Chen; Bettina Purfürst; Bastian Spallek; Tamara T Koopmann; Istvan Baczko; Cristobal G Dos Remedios; Alfred L George; Nanette H Bishopric; Elisabeth M Lodder; Jacques M T de Bakker; Robert Fischer; Ruben Coronel; Arthur A M Wilde; Michael Gotthardt; Carol Ann Remme
Journal:  J Am Coll Cardiol       Date:  2013-11-27       Impact factor: 24.094

6.  Contractile dysfunction of left ventricular cardiomyocytes in patients with pulmonary arterial hypertension.

Authors:  Emmy Manders; Harm-Jan Bogaard; M Louis Handoko; Marielle C van de Veerdonk; Anne Keogh; Nico Westerhof; Ger J M Stienen; Cristobal G Dos Remedios; Marc Humbert; Peter Dorfmüller; Elie Fadel; Christophe Guignabert; Jolanda van der Velden; Anton Vonk-Noordegraaf; Frances S de Man; Coen A C Ottenheijm
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

7.  Differential changes in titin domain phosphorylation increase myofilament stiffness in failing human hearts.

Authors:  Sebastian Kötter; Laurence Gout; Marion Von Frieling-Salewsky; Anna Eliane Müller; Stefan Helling; Katrin Marcus; Cristobal Dos Remedios; Wolfgang A Linke; Martina Krüger
Journal:  Cardiovasc Res       Date:  2013-06-13       Impact factor: 10.787

8.  PKCα-specific phosphorylation of the troponin complex in human myocardium: a functional and proteomics analysis.

Authors:  Viola Kooij; Pingbo Zhang; Sander R Piersma; Vasco Sequeira; Nicky M Boontje; Paul J M Wijnker; Connie R Jiménez; Kornelia E Jaquet; Cris dos Remedios; Anne M Murphy; Jennifer E Van Eyk; Jolanda van der Velden; Ger Jm Stienen
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

9.  Formin follows function: a muscle-specific isoform of FHOD3 is regulated by CK2 phosphorylation and promotes myofibril maintenance.

Authors:  Thomas Iskratsch; Stephan Lange; Joseph Dwyer; Ay Lin Kho; Cris dos Remedios; Elisabeth Ehler
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

10.  Genome-wide identification of expression quantitative trait loci (eQTLs) in human heart.

Authors:  Tamara T Koopmann; Michiel E Adriaens; Perry D Moerland; Roos F Marsman; Margriet L Westerveld; Sean Lal; Taifang Zhang; Christine Q Simmons; Istvan Baczko; Cristobal dos Remedios; Nanette H Bishopric; Andras Varro; Alfred L George; Elisabeth M Lodder; Connie R Bezzina
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

View more
  20 in total

1.  Cris dos Remedios; a Driving Force in Muscle Research.

Authors:  Pauline Bennett
Journal:  Biophys Rev       Date:  2020-06-24

2.  Cris dos Remedios: Sydney Heart Bank and scientific mentorship beyond 2010.

Authors:  Amy Li
Journal:  Biophys Rev       Date:  2020-07-10

3.  Session 1SBP: ASB-BSJ Joint Symposium-current challenges in biophysics centering on biomolecular interactions and the underlying forces.

Authors:  Marc Kvansakul; Takayuki Nishizaka
Journal:  Biophys Rev       Date:  2020-02-03

4.  Multiallelic rare variants support an oligogenic origin of sudden cardiac death in the young.

Authors:  Hager Jaouadi; Yosra Bouyacoub; Sonia Chabrak; Lilia Kraoua; Amira Zaroui; Sahar Elouej; Majdi Nagara; Hamza Dallali; Valérie Delague; Nicolas Levy; Rym Benkhalifa; Rachid Mechmeche; Stéphane Zaffran; Sonia Abdelhak
Journal:  Herz       Date:  2020-01-22       Impact factor: 1.443

5.  Research exchange with Cris: from fluorescence spectroscopy to human myocardium.

Authors:  Shin'ichi Ishiwata
Journal:  Biophys Rev       Date:  2020-06-21

6.  The Sydney Heart Bank: a core facility that goes the extra mile to advance cardiac research.

Authors:  Sabine van Dijk
Journal:  Biophys Rev       Date:  2020-06-10

7.  Prof. Cristobal dos Remedios and the Sydney Heart Bank: enabling translatable heart failure research.

Authors:  Joshua B Holmes; Julian E Stelzer
Journal:  Biophys Rev       Date:  2020-06-22

Review 8.  Imaging tools for assessment of myocardial fibrosis in humans: the need for greater detail.

Authors:  Summer Hassan; Carolyn J Barrett; David J Crossman
Journal:  Biophys Rev       Date:  2020-07-23

9.  Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy.

Authors:  Styliani Vakrou; Yamin Liu; Li Zhu; Gabriela V Greenland; Bahadir Simsek; Virginia B Hebl; Yufan Guan; Kirubel Woldemichael; Conover C Talbot; Miguel A Aon; Ryuya Fukunaga; M Roselle Abraham
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.996

10.  Protein phosphatase 5 regulates titin phosphorylation and function at a sarcomere-associated mechanosensor complex in cardiomyocytes.

Authors:  Judith Krysiak; Andreas Unger; Lisa Beckendorf; Nazha Hamdani; Marion von Frieling-Salewsky; Margaret M Redfield; Cris G Dos Remedios; Farah Sheikh; Ulrich Gergs; Peter Boknik; Wolfgang A Linke
Journal:  Nat Commun       Date:  2018-01-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.